참고문헌
- J. of Pharmacokin and Biopharm v.18 Consideration of individual bioeqivalence Anderson,S.;Hauck,W.W.
- Statistical Decision Theory and Bayesian Analysis Berger,J.O.
- Journal of the American Statistical Association v.91 The intrinsic Bayes Factor for model selection and prediction Berger,J.O.;Pericchi,L.R.
- Design and analysis of bioavailability and bioequivalence studies Chow,S.C.;Liu,J.P.
- Biometrics v.41 A Bayesian analysis of the two-period crossover design for clinical trials Grieve,A.P.
- Corrigenda in Biometrics v.30 The two-period change-over design and its use in clinical trial Grizzle,J.E.
- Journal of Pharmacutical Sciences v.70 Statistical simulation study of new proposed uniformit requirement for bioequivalency studies Haynes,J.D.
- British Journal of Clinical Pharmacology v.8 The two-period corss-over clinical trial Hills,M.;Armitage,P.
- Design and Analysis of Crossover Trials Jones,B.;Kenward,M.G.
- Journal of the Korean Statistical Society v.26 A prdictive two-group multinormal classification rule accounting for model uncertainty Kim,H.J.
- The Korean Communications in Statistics v.6 Assessment and interpretation on bioequivalence for two drug formulations using crossover design Ko,S.G.;Oh,H.S.
- Communications in Statistics-Theory and Methods v.21 no.9 On the assessment of variablitity in bioavailability/bioequivalence studies Liu,J.P.;Chow,S.C.
- The Korean Journal of Applied Statistics v.12 Assessing bioequivalence with two new drug formulations and a reference formulation Oh,H.S.;Ko,S.G.;Kim,J.I.;Park,S.G.
- Journal of the Royal Statistical Society, Ser. B v.44 Bayes Factors for linear and log-linear models with vague prior information Spiegelhalter,D.J.;Smith,A.F.M.